Global Yeast Display-based Antibody Discovery Platform Market Growth (Status and Outlook) 2025-2031

The global Yeast Display-based Antibody Discovery Platform market size is predicted to grow from US$ 604 million in 2025 to US$ 837 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.

Yeast Display is a technology that screens, identifies and optimizes proteins or peptides by displaying them on the surface of yeast cells. It uses yeast as a host and relies on the interaction between proteins expressed on the surface of yeast cells and target molecules to achieve efficient molecular discovery and optimization through high-throughput screening and affinity evolution. The antibody discovery platform based on yeast display is a technology that uses yeast cells as hosts to express and display exogenous antibody fragments.

United States market for Yeast Display-based Antibody Discovery Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Yeast Display-based Antibody Discovery Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Yeast Display-based Antibody Discovery Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Yeast Display-based Antibody Discovery Platform players cover Adagene, Charles River Laboratories, AvantSabre, Creative Biolabs, Adimab, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Yeast Display-based Antibody Discovery Platform Industry Forecast” looks at past sales and reviews total world Yeast Display-based Antibody Discovery Platform sales in 2024, providing a comprehensive analysis by region and market sector of projected Yeast Display-based Antibody Discovery Platform sales for 2025 through 2031. With Yeast Display-based Antibody Discovery Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Yeast Display-based Antibody Discovery Platform industry.

This Insight Report provides a comprehensive analysis of the global Yeast Display-based Antibody Discovery Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Yeast Display-based Antibody Discovery Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Yeast Display-based Antibody Discovery Platform market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Yeast Display-based Antibody Discovery Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Yeast Display-based Antibody Discovery Platform.

This report presents a comprehensive overview, market shares, and growth opportunities of Yeast Display-based Antibody Discovery Platform market by product type, application, key players and key regions and countries.

Segmentation by Type:
Based on Saccharomyces Cerevisiae
Based on Pichia Pastoris

Segmentation by Application:
Basic Research
Clinical Diagnosis
Biologics Development

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Adagene
Charles River Laboratories
AvantSabre
Creative Biolabs
Adimab
Agenus
Specifica Inc.

Please note: The report will take approximately 2 business days to prepare and deliver.